Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking ...

American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...

March 7, 2025 /PRNewswire/ -- Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology.

Taylor, MD, FAAD, will begin her one-year term as president of the American Academy of Dermatology at the close of the AAD's Annual Meeting. Dr. Taylor will lead the world's largest dermatologic ...

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of ...

Larry Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children's Hospital, presented a session at ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic ...

Boni Elewski, M.D., professor and chair of the University of Alabama at Birmingham Department of Dermatology is the 2025 American Academy of Dermatology Gold Medal Award.